Leading stock exchange BSE today said it will drop ING Vysya Bank from BSE 200 and BSE 500 indices from April 16.
The exclusion is on account of ING Vysya Bank Ltd's merger with Kotak Mahindra Bank with effect from April 16, 2015. The stock will be discontinued from trading on the Ex- Date.
In a circular, BSE (formerly known as Bombay Stock Exchange) said that it will exclude ING Vysya Bank from S&P BSE 200 and S&P BSE 500 indices.
In its place, Sun Pharma Advanced Research Company would make an entry in the S&P BSE 200 indice, while Balkrishna Industries would be included in the S&P BSE 500 indice.
These changes would also be effective from April 16.
In a separate circular, the exchange revised the permissible daily trading limit for shares of Plethico Pharmaceuticals and 24 other companies, as part of surveillance action.
The new limits, which ensure that stock prices do not go up or down beyond a level during a trading session, will be effective from tomorrow.
"...The circuit filters has/have been changed from their existing levels in the scrip/s (25) with effect from April 10, 2015," BSE said.
The exchange price of Plethico Pharmaceuticals cannot change by more than 10 per cent in a day.
Its shares today closed at Rs 40.85, a piece on the BSE, up 19.97 per cent.
Apart from Plethico Pharmaceuticals, the exchange has set an upper limit of 10 per cent for Neil Industries, Eastern Gases Piramal Phytocare, ZEN Technologies among others.
